TrialBritish journal of clinical pharmacology1999

Tolterodine does not affect the human in vivo metabolism of the probe drugs caffeine, debrisoquine and omeprazole.

N Brynne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.